Neurofenix
Fast-Forward recovery from stroke, TBI, or spinal cord injury with NeuroBall neuro-rehab platform.
Launch date
Employees
Market cap
-
Enterprise valuation
€25—38m (Dealroom.co estimates Aug 2022.)
Company register number 10194513
London England (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | <1m | <1m | 1.2m | 1.2m |
% growth | - | 43 % | 121 % | 6 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | Seed | ||
N/A | Seed | ||
N/A | $830k | Early VC | |
$60.0k | Grant | ||
N/A | Seed | ||
* | $7.0m | Series A | |
Total Funding | €7.2m |
Related Content
Recent News about Neurofenix
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.